Abstract
Covered stents or stent grafts are exciting new products with multiple applications for patients with vascular disease, including hemodialysis access-related complications. Although most of the current uses of stent grafts in these settings are "off-label" (ie, not approved by the US Food and Drug Administration) several studies are currently underway to provide the necessary data to support their application. It is clear that stent grafts provide a rapid, effective means for endovascular repair of ruptured access vessels. The commercially available devices and their current applications for treating access-related complications, including aneurysms/pseudoaneurysms, venous outflow stenoses, cephalic arch lesions, ruptures, and diffuse access stenoses, will be reviewed in this article. Available data are reported along with our current clinical practice and algorithms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.